Project Narrative: Antiretroviral therapy (ART) during HIV-1 infection suppresses viral replication and prevents immunodeficiency but does not cure the infection. We have developed a novel genetically encoded humanized mouse model system that enables us to distinguish latent cells from bystander cells and are now characterizing latent cells using single cell genomic profiling of cells, to reveal an unprecedented unperturbed view HIV latency. We propose here to use single cell genomics, live dynamic imaging and spatial transcriptomics to probe how latent cells survive stimuli that can activate the virus and the immune system.
|Effective start/end date||19/03/21 → 28/02/23|
- National Institute of Allergy and Infectious Diseases: $630,219.00
- National Institute of Allergy and Infectious Diseases: $628,679.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.